Diabetes Associated Ophthalmic Treatment Market Size - Global Industry Analysis, Market Size, Opportunities and Forecast 2021 - 2028
CHAPTER 1. Industry Overview of Diabetes Associated Ophthalmic Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Diabetes Associated Ophthalmic Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Diabetes Associated Ophthalmic Treatment market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Diabetes Associated Ophthalmic Treatment Market By Type
1.2.3. Diabetes Associated Ophthalmic Treatment Market By Application
1.2.4. Diabetes Associated Ophthalmic Treatment Market By End-User
1.2.5. Diabetes Associated Ophthalmic Treatment Market By Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Sources
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Diabetes Associated Ophthalmic Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Diabetes Associated Ophthalmic Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material Cost
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2020
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2. R&D Status of Major Manufacturers in 2020
CHAPTER 5. Diabetes Associated Ophthalmic Treatment Market By Type
5.1. Introduction
5.2. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) By Type
5.2.1. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
5.2.2. Drugs
5.2.2.1. Drugs Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
5.2.3. Devices
5.2.3.1. Devices Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 6. Diabetes Associated Ophthalmic Treatment Market By Application
6.1. Introduction
6.2. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) By Application
6.2.1. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
6.2.2. Diabetic Retinopathy
6.2.2.1. Diabetic Retinopathy Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.3. Diabetic Macular Edema
6.2.3.1. Diabetic Macular Edema Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.4. Diabetic Associated Macular Degeneration
6.2.4.1. Diabetic Associated Macular Degeneration Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.5. Cataracts
6.2.5.1. Cataracts Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.6. Glaucoma
6.2.6.1. Glaucoma Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.7. Eye Allergy and Infection
6.2.7.1. Eye Allergy and Infection Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.8. Uveitis
6.2.8.1. Uveitis Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
6.2.9. Others
6.2.9.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 7. Diabetes Associated Ophthalmic Treatment Market By End-User
7.1. Introduction
7.2. Diabetes Associated Ophthalmic Treatment Market Revenue By End-User
7.2.1. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast, By End-User, 2017-2028
7.2.2. Hospitals
7.2.2.1. Hospitals Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.3. Ambulatory Surgical Centers (ASCs)
7.2.3.1. Ambulatory Surgical Centers (ASCs) Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.4. Ophthalmic Clinics
7.2.4.1. Ophthalmic Clinics Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
7.2.5. Others
7.2.5.1. Others Market Revenue (US$ Bn) and Growth Rate (%), 2017-2028
CHAPTER 8. North America Diabetes Associated Ophthalmic Treatment Market By Country
8.1. North America Diabetes Associated Ophthalmic Treatment Market Overview
8.2. U.S.
8.2.1. U.S. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
8.2.2. U.S. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
8.2.3. U.S. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
8.3. Canada
8.3.1. Canada Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
8.3.2. Canada Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
8.3.3. Canada Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
8.4. North America PEST Analysis
CHAPTER 9. Europe Diabetes Associated Ophthalmic Treatment Market By Country
9.1. Europe Diabetes Associated Ophthalmic Treatment Market Overview
9.2. U.K.
9.2.1. U.K. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.2.2. U.K. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.2.3. U.K. Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.3. Germany
9.3.1. Germany Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.3.2. Germany Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.3.3. Germany Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.4. France
9.4.1. France Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.4.2. France Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.4.3. France Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.5. Spain
9.5.1. Spain Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.5.2. Spain Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.5.3. Spain Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.6. Rest of Europe
9.6.1. Rest of Europe Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
9.6.2. Rest of Europe Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
9.6.3. Rest of Europe Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Diabetes Associated Ophthalmic Treatment Market By Country
10.1. Asia Pacific Diabetes Associated Ophthalmic Treatment Market Overview
10.2. China
10.2.1. China Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.2.2. China Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.2.3. China Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.3. Japan
10.3.1. Japan Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.3.2. Japan Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.3.3. Japan Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.4. India
10.4.1. India Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.4.2. India Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.4.3. India Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.5. Australia
10.5.1. Australia Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.5.2. Australia Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.5.3. Australia Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.6. South Korea
10.6.1. South Korea Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.6.2. South Korea Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.6.3. South Korea Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
10.7.2. Rest of Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
10.7.3. Rest of Asia-Pacific Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Diabetes Associated Ophthalmic Treatment Market By Country
11.1. Latin America Diabetes Associated Ophthalmic Treatment Market Overview
11.2. Brazil
11.2.1. Brazil Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.2.2. Brazil Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.2.3. Brazil Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.3. Mexico
11.3.1. Mexico Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.3.2. Mexico Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.3.3. Mexico Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.4. Rest of Latin America
11.4.1. Rest of Latin America Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
11.4.2. Rest of Latin America Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
11.4.3. Rest of Latin America Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Diabetes Associated Ophthalmic Treatment Market By Country
12.1. Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Overview
12.2. GCC
12.2.1. GCC Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.2.2. GCC Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.2.3. GCC Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.3. South Africa
12.3.1. South Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.3.2. South Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.3.3. South Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Type, 2017-2028
12.4.2. Rest of Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By Application, 2017-2028
12.4.3. Rest of Middle East & Africa Diabetes Associated Ophthalmic Treatment Market Revenue (US$ Bn) and Forecast By End-User, 2017-2028
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Diabetes Associated Ophthalmic Treatment Market
13.1. Diabetes Associated Ophthalmic Treatment Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Diabetes Associated Ophthalmic Treatment market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/Sales Agreements
CHAPTER 14. Company Profile
14.1. Alcon
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (US$ Bn), 2020
14.1.3.2. Alcon 2020 Diabetes Associated Ophthalmic Treatment Business Regional Distribution
14.1.4. Type/ Service and Specification
14.1.5. Recent Developments & Business Strategy
14.1.6. Manufacturing Plant Footprint Analysis
14.2. Allergan
14.3. Abbott Medical Optics
14.4. Bausch Health
14.5. Bayer AG
14.6. Carl Zeiss Meditec
14.7. Ellex Medical Lasers Ltd.
14.8. F. Hoffmann-La Roche Ltd
14.9. Genentech, Inc.
14.10. IRIDEX Corp.
14.11. Johnson & Johnson Services, Inc.
14.12. Lumenis
14.13. Novartis AG
14.14. Pfizer, Inc.
14.15. Quantel
14.16. Santen Pharmaceutical Co. Ltd.
14.17. Topcon Corp.